United States of America
Short Communication
Inert Cellulose Powder in the Treatment of Seasonal Allergic Rhinitis
Author(s): Minov JB, Karadzinska-Bislimovska J, Petrova T, Vasilevska K, Stoleski S and Mijakoski DMinov JB, Karadzinska-Bislimovska J, Petrova T, Vasilevska K, Stoleski S and Mijakoski D
Objective: To assess efficacy and safety of inert cellulose powder (ICP) in the treatment of mild seasonal allergic rhinitis (SAR). Methods: An observational, non-randomized, open study including 74 examinees suffering from mild SAR was conducted. The study subjects were divided in two groups, Group 1 (G1) and Group 2 (G2). The study subjects from G1 were treated 10 days with oral cetirizine and ICP, while the study subjects from G2 were treated 10 days only with oral cetirizine. The treatment outcomes were evaluated after five and 10 days by self-assessment of the symptoms on a five-point scale. Results: In both groups improvement of the symptoms five and 10 days after the treatment was registered. There was significantly higher prevalence of the G1 study subjects in the point 4 (“major relief, casual sneezing”) five days after beginning of the treatment (43.2% vs. 18.9%;.. Read More»
DOI:
10.4172/2161-105X.1000388
Pulmonary & Respiratory Medicine received 1690 citations as per Google Scholar report